Table 4 Uveitis treatment type by eye and by patient including drops, periocular and intravitreal injections, and systemic treatments
From: Analyzing the demographics of patients with uveitis in an indigent, urban population
N = 366 eyes | No. (%) |
|---|---|
Corticosteroid Drops Prednisolone Acetate 1% Difluprednate 0.05% | 349 (95.3) 291 (79.5) 58 (15.8) |
Regional Steroid Injection(s) Sub-tenon Triamcinolone Sub-tenon Triamcinolone then IVTA IVTA then Dexamethasone 0.7 mg implant Dexamethasone 0.7 mg implant | 22 (6) 13 (3.6) 3 (0.8) 3 (0.8) 3 (0.8) |
Antimicrobial treatment (eye level) | |
Topical ganciclovir | 3 (0.8) |
Intravitreal antibiotics | 2 (0.5) |
Trifluridine | 1 (0.3) |
Ofloxacin | 1 (0.3) |
Glaucoma Drops | 43 (11.7) |
Glaucoma Surgery or Lasers* Laser peripheral iridotomy (LPI) Trabeculectomy Tube | 9 (2.5) 2 (0.5) 6 (1.6) 3 (0.8) |
N = 270 patients | |
Systemic Prednisone | 44 (16.3) |
Antimicrobial treatment (person level) | |
Valacyclovir | 7 (2.6) |
Acyclovir | 3 (1.1) |
Famvir | 3 (1.1) |
Topical ganciclovir | 3 (1.1) |
Trimethoprim sulfamethoxazole | 3 (1.1) |
Valganciclovir | 1 (0.4) |
Intravenous antibiotics | 1 (0.4) |
Immunosuppressive Agents Overall | 24 (8.9) |
Antimetabolites • Methotrexate • Mycophenolate mofetil • Azathioprine | 18 (6.7) 13 3 2 |
Biologic Agents • Infliximab • Adalimumab • Abatacept | 11 (4.1) 7 3 1 |